An Open Trial of Relapse Prevention Therapy for Smokers With Schizophrenia

REFERENCES

• Adler , L. , Hoffer , L. , Griffith , J. , Waldo , M. and Freedman , R. 1992 . Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics . Biological Psychiatry , 32 : 607 – 616 . doi: 10.1016/0006–3223(92)90073–9
   PubMed Web of Science ®Google Scholar
• Adler , L. , Hoffer , L. , Wiser , A. and Freedman , R. 1993 . Normalization of auditory physiology by cigarette smoking in schizophrenic patients . American Journal of Psychiatry , 150 ( 12 ) : 1856 – 1861 .
   PubMed Web of Science ®Google Scholar
• Agboola , S. , McNeill , A. , Coleman , T. and Bee , J. L. 2010 . A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers . Addiction , 105 : 1362 – 1380 . doi: 10.1111/j.1360–0443.2010.02996.x
   PubMed Web of Science ®Google Scholar
• Avila , M. T. , Sherr , J. D. , Hong , E. , Myers , C. S. and Thaker , G. K. 2003 . Effects of nicotine on leading saccades during smooth pursuit eye movements in smokers and nonsmokers with schizophrenia . Neuropsychopharmacology , 28 ( 12 ) : 2184 – 2191 . doi: 10.1038/sj.npp.1300265
   PubMed Web of Science ®Google Scholar
• Baker , A. , Richmond , R. , Haile , M. , Lewin , T. J. , Carr , V. J. , Taylor , R. L. and Wilhelm , K. 2006 . A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder . American Journal of Psychiatry , 163 ( 11 ) : 1934 – 1942 . doi: 10.1176/appi.ajp.163.11. 1934
   PubMed Web of Science ®Google Scholar
• Barr , R. S. , Culhane , M. A. , Jubelt , L. E. , Mufti , R. S. , Dyer , M. A. , Weiss , A. P. and Evins , A. E. 2007 . The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls . Neuropsychopharmacology , 33 ( 3 ) : 480 – 490 . doi: 10.1038/sj.npp.1301423
   PubMed Web of Science ®Google Scholar
• Breese , C. R. , Lee , M. J. , Adams , C. E. , Sullivan , B. , Logel , J. , Gillen , K. M. and Leonard , S. 2000 . Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia . Neuropsychopharmacology , 23 ( 4 ) : 351 – 364 . doi: 10.1016/S0893–133X(00)00121–4
   PubMed Web of Science ®Google Scholar
• Brown , S. , Inskip , H. and Barraclough , B. 2000 . Causes of the excess mortality of schizophrenia . British Journal of Psychiatry , 177 : 212 – 217 .
   PubMed Web of Science ®Google Scholar
• Buchanan , R. W. , Kreyenbuhl , J. , Kelly , D. L. , Noel , J. M. , Boggs , D. L. , Fischer , B. A. and &Keller , W. 2009 . The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements . Schizophrenia Bulletin , 36 ( 1 ) : 71 – 93 . doi: 10.1093/schbul/ sbp116
   PubMed Web of Science ®Google Scholar
• Curkendall , S. M. , Mo , J. , Glasser , D. B. , Rose Stang , M. and Jones , J. K. 2004 . Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada . Journal of Clinical Psychiatry , 65 ( 5 ) : 715 – 720 .
   PubMed Web of Science ®Google Scholar
• de Leon , J. , Dadvand , M. , Canuso , C. , White , A. O. , Stanilla , J. K. and Simpson , G. M. 1995 . Schizophrenia and smoking: An epidemiological survey in a state hospital . American Journal of Psychiatry , 152 ( 3 ) : 453 – 455 .
   PubMed Web of Science ®Google Scholar
• Durany , N. , Zochling , R. , Boissl , K. W. , Paulus , W. , Ransmayr , G. , Tatschner , T. and Riederer , P. 2000 . Human post-mortem striatal alpha4beta2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome . Neuroscience Letters , 287 ( 2 ) : 109 – 112 . doi:S0304–3940(00)01144–7
   PubMed Web of Science ®Google Scholar
• Enger , C. , Weatherby , L. , Reynolds , R. F. , Glasser , D. B. and Walker , A. M. 2004 . Serious cardiovascular events and mortality among patients with schizophrenia . Journal of Nervous and Mental Disease , 192 ( 1 ) : 19 – 27 . doi:00005053-200401000-00004
   PubMed Web of Science ®Google Scholar
• Evins , A. E. , Cather , C. , Culhane , M. A. , Birnbaum , A. , Horowitz , J. , Hsieh , E. and Goff , D. C. 2007 . A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia . Journal of Clinical Psychopharmacology , 27 ( 4 ) : 380 – 386 . doi: 10.1097/01.jcp.0b013e3180ca86fa
   PubMed Web of Science ®Google Scholar
• Evins , A. E. , Cather , C. , Deckersbach , T. , Freudenreich , O. , Culhane , M. A. , Olm-Shipman , C. M. and Rigotti , N. A. 2005 . A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia . Journal of Clinical Psychopharmacology , 25 ( 3 ) : 218 – 225 . doi:00004714–200506000-00004
   PubMed Web of Science ®Google Scholar
• Fagerström , K. 1978 . Measuring degrees of physical dependence to tobacco smoking with reference to individuation of treatment . Addictive Behaviors , 3 : 235 – 241 .
   PubMed Web of Science ®Google Scholar
• Fiore , M. , Bailey , W. and Cohen , S. 1996 . Smoking cessation. Clinical practice guideline No. 18 , Rockville , MD : Agency for Health Care Policy and Research . (No. AHCPR publication no. 96–0692)
   Google Scholar
• Fiore , M. C. , Jaén , C. R. and &Baker , T. B. 2008 . Treating tobacco use and dependence: 2008 update. Clinical practice guideline , Rockville , MD : US Department of Health and Human Services, Public Health Service .
   Google Scholar
• Ferron , J. C. , Brunette , M. F. , He , X. , Xie , H. , McHugo , G. J. and Drake , R. E. 2011 . Course of smoking and quit attempts among clients with co-occurring severe mental illness and substance use disorders . Psychiatric Services , 62 : 353 – 359 . doi: 10.1176/appi.ps.62.4.353
   PubMed Web of Science ®Google Scholar
• George , T. , Vessicchio , J. , Sacco , K. , Weinberger , A. , Dudas , M. , Allen , T. and Jatlow , P. I. 2008 . A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation . Biological Psychiatry , 63 : 1092 – 1096 . doi: 10.1016/j.biopsych.2007.11.002
   PubMed Web of Science ®Google Scholar
• George , T. , Vessicchio , J. , Termine , A. , Bregartner , T. , Feingold , A. , Rounsaville , B. and Kosten , T. R. 2002 . A placebo controlled trial of bupropion for smoking cessation in schizophrenia . Biological Psychiatry , 52 ( 1 ) : 53 – 61 . doi:S0006322302013392
   PubMed Web of Science ®Google Scholar
• George , T. , Ziedonis , D. , Feingold , A. , Pepper , W. , Satterburg , C. , Winkel , J. and Kosten , T. R. 2000 . Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia . American Journal of Psychiatry , 157 ( 11 ) : 1835 – 1842 .
   PubMed Web of Science ®Google Scholar
• Goff , D. C. , Cather , C. , Evins , A. E. , Henderson , D. C. , Freudenreich , O. , Copeland , P. M. and Sacks , F. M. 2005 . Medical morbidity and mortality in schizophrenia: Guidelines for psychiatrists . Journal of Clinical Psychiatry , 66 ( 2 ) : 183 – 194 .
   PubMed Web of Science ®Google Scholar
• Hajek , P. , Stead , L. F. , West , R. , Jarvis , M. and Lancaster , T. 2009 . Relapse prevention interventions for smoking cessation . Cochrane Database of Systematic Reviews , doi: 10.1002/14651858.CD003999.pub3
   Google Scholar
• Hall , S. M. , Humfleet , G. L. , Reus , V. I. , Munoz , R. F. and Cullen , J. 2004 . Extended nortriptyline and psychological treatment for cigarette smoking . American Journal of Psychiatry , 161 ( 11 ) : 2100 – 2107 . doi: 10.1176/appi.ajp.161.11.2100
   PubMed Web of Science ®Google Scholar
• Hays , J. T. , Hurt , R. D. , Rigotti , N. A. , Niaura , R. , Gonzales , D. , Durcan , M. J. and White , J. D. 2001 . Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. A randomized, controlled trial . Annals of Internal Medicine , 135 ( 6 ) : 423 – 433 . doi:200109180–00011
   PubMed Web of Science ®Google Scholar
• Horst , W. D. , Klein , M. W. , Williams , D. and Werder , S. F. 2005 . Extended use of nicotine replacement therapy to maintain smoking cessation in person with schizophrenia . Neuropsychiatric Disease and Treatment , I ( 4 ) : 349 – 355 .
   Google Scholar
• Hughes , J. 1986 . Prevalence of smoking among psychiatric outpatients . American Journal of Psychiatry , 143 : 993 – 997 .
   PubMed Web of Science ®Google Scholar
• Joukamaa , M. , Heliovaara , M. , Knekt , P. , Aromaa , A. , Raitasalo , R. and Lehtinen , V. 2001 . Mental disorders and cause-specific mortality . British Journal of Psychiatry , 179 : 498 – 502 .
   PubMed Web of Science ®Google Scholar
• Julbelt , L. E. , Barr , R. S. , Goff , D. C. , Logvineko , T. , Weiss , A. P. and &Evins , A. E. 2008 . Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia . Psychopharmacology , 199 ( 1 ) : 89 – 98 . doi: 10.1007/s00213–008-1133–8
   PubMed Web of Science ®Google Scholar
• Olincy , A. , Young , D. A. and Freedman , R. 1997 . Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers . Biological Psychiatry , 42 ( 1 ) : 1 – 5 . doi: 10.1016/S0006–3223(96)00302–2
   PubMed Web of Science ®Google Scholar
• Smith , R. C. , Lindenmayer , J. P. , Davis , J. M. , Cornwell , J. , Noth , K. , Gupta , S. and Lajtha , A. 2009 . Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder . Schizophrenia Research , 110 ( 1–3 ) : 149 – 155 . doi: 10.1016/j.schres.2009.02. 001
   PubMed Web of Science ®Google Scholar
• Strasser , K. , Moeller-Saxone , K. , Meadows , G. , Hocking , B. , Stanton , J. and Kee , P. 2002 . Smoking cessation in schizophrenia. General practice guidelines . Australian Family Physician , 31 ( 1 ) : 21 – 24 .
   PubMedGoogle Scholar
• Sudders , M. 2002 . Massachusetts Department of Mental Health Mortality Report 2000 [Monograph] , Boston , MA : Commonwealth of Massachusetts Executive Office of Health and Human Services Department of Mental Health .
   Google Scholar
• Tidey , J. and Colby , S. 2011 . Characterization of 72-hr abstinence effects in smokers with schizophrenia and controls. Preliminary result , Toronto , , Canada : Paper presented at the annual meeting of the Society for Research on Nicotine and Tobacco .
   Google Scholar
• Tsoi , D. , Porwal , M. and Webster , A. 2010 . Interventions for smoking cessation and reduction in individuals with schizophrenia . Cochrane Database of Systematic Reviews , 6 doi: 10.1002/14651858.CD007253.pub2
   Google Scholar
• Weiner , E. , Ball , M. P. , Buchholz , A. S. , Gold , J. M. , Evins , A. E. , McMahon , R. P. and Buchanan , R. W. 2012 . Bupropion sustained release added to group support for smoking cessation in schizophrenia: A new randomized trial and a meta-analysis . Journal of Clinical Psychiatry , 73 ( 1 ) : 95 – 102 . doi: 10.4088/JCP.10m06143gre
   PubMed Web of Science ®Google Scholar
• Williams , J. , Gandhi , K. , Lu , S. , Kumar , S. , Shen , J. , Foulds , J. and Benowitz , N. L. 2010 . Higher nicotine levels in schizophrenia compared with controls after smoking a single cigarette . Nicotine & Tobacco Research , 12 : 855 – 859 . doi: 10.1093/ntr/ntq102
   PubMed Web of Science ®Google Scholar